Free download account of OCN Practice test

At, we surrender substantial and to date Medical OCN genuine Questions and Answers that are as of later needed for the Passing OCN test. We truly enable individuals to further develop their insight to answer Oncology Certified Nurse - 2022 Latest Questions and pass-ensure. It is a most ideal decision to speed up your situation as a specialist in your Organization.

Exam Code: OCN Practice exam 2022 by team
OCN Oncology Certified Nurse - 2022

Exam ID : OCN
Exam Title : Oncology Certified Nurse (OCN®)
Questions : 165
Duration : 3 hours
Exam Type : multiple-choice

Test Content Outline (Effective 2020)
I. Care Continuum - 19%
A. Health promotion and disease prevention (e.g., high-risk behaviors; preventive health practices)
B. Screening and early detection
C. Navigation
D. Advance care planning (e.g., advance directives)
E. Epidemiology
1. Modifiable risk factors (e.g., smoking, diet, exercise, occupation)
2. Non-modifiable risk factors (e.g., age, gender, genetics)
F. Survivorship
1. Rehabilitation
2. Recurrence concerns
3. Financial concerns
4. Employment concerns
5. Insurance concerns
6. Family and social support concerns
7. Sexuality concerns
G. Treatment-related considerations
1. Delayed-onset side effects
2. Chronic side effects
3. Secondary malignancies
4. Follow-up care
H. End-of-life care
1. Grief
2. Bereavement
3. Hospice care
4. Caregiver support
5. Interdisciplinary team
6. Pharmacologic comfort measures
7. Non-pharmacologic comfort measures
II. Oncology Nursing Practice - 17 %
A. Scientific basis
1. Carcinogenesis
2. Immunology
3. Clinical trials (e.g., research protocols)
B. Site-specific cancer considerations
1. Pathophysiology
2. Common metastatic locations
3. Diagnostic measures
4. Prognosis
5. Classification
6. Staging
7. Histological grading
C. Scope, standards, and related issues
1. Standards of care (nursing process)
2. Legal (including documentation)
3. Accreditation (e.g., The Joint Commission)
4. Self-care (e.g., managing compassion fatigue)
D. Standards of professional performance
1. Ethics (e.g., patient advocacy)
2. Education
3. Evidence-based practice (e.g., Putting Evidence Into Practice (PEP) guidelines) and research
4. Quality of practice
5. Communication
6. Leadership
7. Collaboration
8. Professional practice evaluation
9. Resource utilization
10. Environmental health (e.g., safety, personal protective equipment, safe handling)
III. Treatment Modalities - 19%
A. Surgery
B. Blood and marrow transplant
C. Radiation therapy
D. Chemotherapy
E. Biotherapy
F. Immunotherapy
G. Vascular Access Devices (VADs) for treatment administration
H. Targeted Therapy
IV. Symptom Management and Palliative Care - 23%
A. Etiology and patterns of symptoms (acute, chronic, late)
B. Anatomical and surgical alterations (e.g., lymphedema, ostomy, site-specific radiation)
C. Pharmacologic interventions
D. Complementary and integrative modalities (e.g., massage, acupuncture, herbal supplements)
E. Palliative care considerations
F. Alterations in functioning
1. Hematologic
2. Immune system
3. Gastrointestinal
4. Genitourinary
5. Integumentary
6. Respiratory
7. Cardiovascular
8. Neurological
9. Musculoskeletal
10. Nutrition
11. Cognition
12. Energy level (i.e., fatigue)
V. Oncologic Emergencies - 12%
A. Disseminated intravascular coagulation (DIC)
B. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
C. Sepsis (including septic shock)
D. Tumor lysis syndrome
E. Hypersensitivity
F. Anaphylaxis
G. Hypercalcemia
H. Cardiac tamponade
I. Spinal cord compression
J. Superior vena cava syndrome
K. Increased intracranial pressure
L. Obstructions (bowel and urinary)
M. Pneumonitis
N. Extravasations
VI. Psychosocial Dimensions of Care - 10%
A. Cultural, spiritual, and religious diversity
B. Financial concerns (including available resources)
C. Altered body image
D. Learning styles and barriers to learning
E. Social relationships and family dynamics
F. Coping mechanisms and skills
G. Support
1. Patient (i.e., individual and group)
2. Caregiver (including family)
H. Psychosocial considerations
1. Anxiety
2. Loss and grief
3. Depression
4. Loss of personal control
I. Sexuality
1. Reproductive issues (e.g., contraception, fertility)
2. Sexual dysfunction (e.g., physical and psychological effects)
3. Intimacy

Oncology Certified Nurse - 2022
Medical Certified questions
Killexams : Medical Certified questions - BingNews Search results Killexams : Medical Certified questions - BingNews Killexams : Study questions the medical privacy of forensic samples

Watch any episode of "CSI," and a character will use forensic DNA profiling to identify a criminal. A new study from San Francisco State University suggests that these forensic profiles may indirectly reveal medical information—perhaps even those of crime victims—contrary to what the legal field has believed for nearly 30 years. The findings, now published in the Proceedings of the National Academy of Sciences, could have ethical and legal implications.

"The central assumption when choosing those [forensic] markers was that there wouldn't be any information about the individuals whatsoever aside from identification. Our paper challenges that assumption," said first author Mayra Bañuelos, who started working on the project as a San Francisco State undergraduate and is now a Ph.D. student at Brown University.

Law enforcement uses the Combined DNA Index System (CODIS), a system organizing criminal justice DNA databases that uses specific genetic markers to identify individuals. Crime labs from national, state and local levels contribute to these databases and provide profiles from samples collected from crime scene evidence, convicted offenders, felony arrestees, missing persons and more. Law officials can use the database to try to match samples found in an investigation to profiles already stored in the database.

CODIS profiles consist of an individual's genetic variants as a set of short tandem repeats (STRs), sequences of DNA that repeat at various frequencies among individuals. Since the '90s, 20 STRs have been chosen for forensic CODIS profiling specifically because it was believed they did not relay . If these profiles contained any trait information, then there could be issues about medical privacy.

"But that assumption hasn't had much investigation in a long time, and we know a lot more about the genome now than we did back then," explained SF State Associate Professor of Biology Rori Rohlfs, who led this project.

The assumption that only criminals are sampled is also not completely accurate. "It actually also includes victims of crime and people that may have been at crime scenes. You have these huge databases including a lot of people that are not necessarily criminals," Bañuelos said. "I believe also that accessibility to these databases varies a lot according to a jurisdiction."

The researchers explained that other papers have found associations between other (non-CODIS) STRs and disease or gene expression. With that in mind, the SF State team wanted to understand the relationship between the CODIS STR markers and gene expression.

Rohfls' lab used publicly available data (1000 Genome Project) and genetic models to investigate the relationship between CODIS markers and gene expression. Of the 20 CODIS markers, they found six associations between CODIS markers and gene expression of nearby genes in white blood cell lines from more than 400 unrelated individuals in the database.

Credit: San Francisco State University

"In some genes, gene expression change has been associated with ," Bañuelos explained, citing prior research. "[In this study,] we indirectly know there is an association between these CODIS genotypes and some change in genes that can lead to illness."

The authors note three associations to genes (CSF1R, LARS2, KDSR) that were particularly interesting. Prior literature shows that mutations and changes in gene expression of CSF1R can be tied to psychiatric conditions (depression and schizophrenia). Mutations and changes in the other genes have been connected to Perrault syndrome, MELAS syndrome, severe skin and platelet conditions and more, the scientists note in the PNAS (Proceedings of the National Academy of Sciences) paper. If CODIS markers can be connected to the expression of linked to disease and health, then it means that the data in the CODIS could compromise an individual's medical privacy.

"Our paper in some ways is like the tip of the iceberg," Rohlfs said, admitting that she was surprised to find associations in a relatively small demo size. The project itself simply started as an undergraduate exploration project. Eight of the 11 authors were, like Bañuelos, undergraduates at SF State when the project began.

"It raises the question: If we did a more expansive [genetic] study, would we find even more information that would be revealed by CODIS profiles?" Rohlfs asked.

Bañuelos and Rohlfs are curious to know what they'd find if they looked at a larger dataset of more diverse populations—their current dataset is predominantly European. Their analysis was also limited to white blood cells. What relationships would they find if they looked in other tissues?

These are important lines of inquiry because the current dataset doesn't represent the general population. Furthermore, Latino and African American communities are overrepresented in these CODIS databases, Bañuelos explained.

Additional studies are needed to better flush out the relationship between CODIS and medical information. However, the researchers point out that if CODIS profiles contain medical information, there could be major implications.

"If [these CODIS profiles] contain medical information, then their treatment would need to be consistent with the way we protect medical information in the United States. We would have to have policies that regulate the seizure, storage and sharing of these profiles," Rohlfs added.

More information: Mayra M. Bañuelos et al, Associations between forensic loci and expression levels of neighboring genes may compromise medical privacy, Proceedings of the National Academy of Sciences (2022). DOI: 10.1073/pnas.2121024119

Citation: Study questions the medical privacy of forensic samples (2022, October 12) retrieved 17 October 2022 from

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Wed, 12 Oct 2022 02:18:00 -0500 en text/html
Killexams : People Are Flocking to a Hotline With Their Miscarriage and Abortion Questions

When a couple of doctors got together in 2019 to create a free hotline for people who have questions about their miscarriage or abortion, they could never have envisioned how popular their service, the Miscarriage and Abortion Hotline, would become.

But with many women facing laws in their state making abortions illegal, and with federal regulatory changes allowing abortion pills to be sent by mail and taken without medical assistance, the demand for this service is growing.

“The goal of the hotline is to help people safely manage their abortions and miscarriages, so they don’t have to unnecessarily go to the hospital,” says April Lockley, DO, a family medicine physician in New York City and the medical director of the hotline, which is also known as the M+A Hotline. “We are there to support people during the process.”

Experienced Professionals Staff the Hotline

Anyone who has a question about a planned, ongoing, or latest abortion or miscarriage can call or text the hotline for free, at 833-246-2632.